BusinessVoyager Therapeutics Announces FDA Clearance of Investigational New Drug Application for VY-AADC for Advanced Parkinson’s DiseaseBy Nasdaq OMXJan 23, 2018, 12:04 PM UTC
BusinessaTyr Pharma Announces Poster Presentation at ASCO-SITC Clinical Immuno-Oncology SymposiumBy Nasdaq OMXDec 21, 2017, 1:01 PM UTC
BusinessAXIM Biotech Announces Successful Completion of Pre-IND Meeting with FDA on Comparable Product to Marinol; Green Light from FDA for IND SubmissionBy Nasdaq OMXDec 12, 2017, 2:01 PM UTC
Business2X Oncology Obtains Investigational New Drug Application for 2X-111 Glutathione Enhanced PEGylated Liposomal DoxorubicinBy Nasdaq OMXJun 8, 2017, 1:06 PM UTC
BusinessTESARO Announces Submission of Investigational New Drug Application for Anti-LAG Antibody TSR-033 to the U.S. FDABy Nasdaq OMXMay 1, 2017, 12:32 PM UTC
BusinessTESARO Announces Submission of Investigational New Drug Application for Anti-LAG Antibody TSR-033 to the U.S. FDABy Nasdaq OMXMay 1, 2017, 12:32 PM UTC
BusinessTESARO Announces Submission of Investigational New Drug Application for Anti-LAG Antibody TSR-033 to the U.S. FDABy Nasdaq OMXMay 1, 2017, 12:32 PM UTC
BusinessAkari Therapeutics Announces FDA Allowance of IND for Clinical Development of Coversin in PNHBy Nasdaq OMXJan 3, 2017, 12:01 PM UTC
